Doctor AI will see you now — eventually. A new study from The Journal of Clinical Endocrinology & Metabolism has demonstrated how artificial intelligence (AI) can enhance the accuracy of diagnosing Cushing’s syndrome (CS), a rare but serious endocrine disorder caused by excessive cortisol production. Cushing’s syndrome is characterized by a broad spectrum of symptoms,...
Endocrine Society Advocates to Protect Funding for NIH and Reauthorize SDP on Capitol Hill On Wednesday, March 12, the Endocrine Society hosted a Researcher Hill Day and brought members from across the country to Washington, D.C., to meet with their senators and representatives and discuss the importance of completing the appropriations process for Fiscal Year...
The Endocrine Society is extremely disappointed the administration has chosen not to finalize a rule that would have made anti-obesity medications more accessible to millions of Americans with obesity. The administration decided not to implement a proposal that would have allowed Medicare and Medicaid to cover anti-obesity medications for weight loss. Many Medicare and Medicaid...
Andrea C. Gore, PhD, of the University of Texas in Austin, discusses her recent Journal of the Endocrine Society paper, which found that early-life exposure to a class of endocrine-disrupting chemicals called polychlorinated biphenyls – banned for decades but persistent in the environment — may lead to behavioral problems later in life. Late last year,...
March 2025 has seen “Stand up for Science” events take place in cities in both the U.S. and France. Reliable, reputable research is essential for fostering advances in human health. The Endocrine Society is extremely active in advocating for science funding and health policy, with particular emphasis on the endocrine space. The Society also has...
Recently I was watching a couple of movies from the 1970s; one was a drama filmed in New York City and the other was a documentary filmed in California. There were plenty of random shots of people in streets as well as crowds at various events throughout both. However, one thing about both movies that...
A major reorganization of the U.S. Department of Health and Human Services (HHS) — including massive cuts to the federal workforce — threatens scientific progress that drives our economy and improves the public’s health. Slashing federal funding and staff will hobble the very agencies that fuel medical discoveries and approve new treatments. In addition, the...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * CABOMETYX® Receives FDA Approval to Treat Neuroendocrine Tumors On March 26, Exelixis, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older with...